Characteristics of Tuberculosis Infection in Rheumatic Disease

A retrospective study evaluating the characteristics of tuberculosis infection in patients of rheumatic disease.

Completed

Looking for future studies?

Key information

Conditions

Tuberculosis Actinomycetales Infections Autoimmune Diseases Bacterial Infections Bacterial Infections and Mycoses Gram-Positive Bacterial Infections Immune System Diseases Infections Mycobacterium Infections

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

National Taiwan University Hospital

Taipei, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The patients with International Classification of Diseases (ICD) codes of rheumatic diseases during 2006-2017
Definite evidence of tuberculosis infection

Exclusion criteria

HIV, malignancy, not follow-up rheumatic disease in National Taiwan University Hospital, younger than 20-year-old, refusing attend research

Treatment and study plan

No intervention

Other

We group the patients according to the outcome (survival vs mortality)

Primary outcomes

Mortality

Time frame: approximately 6 months

Death of any cause (The definition of TB mortality from WHO is death of any cause during TB treatment.)

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

Retrospective Analysis of Tuberculosis in Rheumatic Diseases for Epidemiology, Risk Factors, Disease Presentation, Complications, Treatment, and Prognosis

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2019
First posted: Nov 9, 2018
Registry last updated: Dec 11, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed